InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Slagel Dean. Director active across 1 company, notably Cara Therapeutics, Inc.. In total, 4 reports have been published. Split: 0 buy · 4 sells. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Slagel Dean is a declarant linked to Cara Therapeutics, Inc. (XNAS) as a Director. The record shows 4 filings in total, all in the recent sample, over the period from 2016-01-05 to 2016-01-12, with a modal transaction nature listed as sell and buy and sell amounts of 0 in that sample.